Identity of tendon stem cells - how much do we know?

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 1, 2013, Pages 55-64

  Lui, Pauline Po Yee ^a,b  

^a Prince of Wales Hospital   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

In vivo identity; Stem cell niche; Tendon injury; Tendon stem cells

Indexed keywords

OXYGEN;

ADULT STEM CELL; ANTIBODY SPECIFICITY; CYTOLOGY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MULTIPOTENT STEM CELL; PATHOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; TENDON; TENDON INJURY; WOUND HEALING;

ADULT STEM CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMANS; MULTIPOTENT STEM CELLS; ORGAN SPECIFICITY; OXYGEN; SIGNAL TRANSDUCTION; STEM CELL NICHE; TENDON INJURIES; TENDONS; WOUND HEALING;

EID: 84873147732     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12007     Document Type: Review

References (85)

1. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med. 2007; 13: 1219-27.
2. Zhang J, Wang JHC. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord. 2010; 1: 10.
3. Rui YF, Lui PPY, Li G, et al. Isolation and characterization of multi-potent rat tendon-derived stem cells. Tissue Eng Part A. 2010; 16: 1549-58.
4. Lovati AB, Corradetti B, Lange Consiglio A, et al. Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents. 2011; 25: S75-84.
5. Sakaguchi Y, Sekiya I, Yagishita K, et al. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005; 52: 2521-9.
6. Tan Q, Lui PPY, Rui YF, et al. Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. Tissue Eng Part A. 2012; 18: 840-51.
7. Rui YF, Lui PPY, Lee YW, et al. Higher BMP receptors expression and BMP-2-induced osteogenic differentiation in tendon-derived stem cells compared to bone marrow-derived mesenchymal stem cells. Int Orthop. 2012; 36: 1099-107.
8. Ni M, Lui PPY, Rui YF, et al. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model. J Orthop Res. 2012; 30: 613-9.
9. Shen W, Chen J, Yin Z, et al. Allogenous tendon stem/progenitor cells in silk scaffold for functional shoulder repair. Cell Transplant. 2012; 21: 943-58.
10. Tan Q, Lui PP, Rui YF. Effect of in vitro passaging on the stem cell-related properties of tendon-derived stem cells-implications in tissue engineering. Stem Cells Dev. 2012; 21: 790-800.
11. Zhang J, Wang JHC. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med. 2010; 38: 2477-86.
12. Scutt N, Rolf CG, Scutt A. Glucocorticoids inhibit tenocyte proliferation and tendon progenitor cell recruitment. J Orthop Res. 2006; 24: 173-82.
13. Zhang J, Keenan C, Wang JHC. The effects of dexamethasone on human patellar tendon stem cells: implications for dexamethasone treatment of tendon injury. J Orthop Res. 2013; 31: 105-10.
14. Haasters F, Polzer H, Prall WC, et al. Bupivacaine, ropivacaine, and morphine: comparison of toxicity on human hamstring-derived stem/progenitor cells. Knee Surg Sports Traumatol Arthrosc. 2011; 19: 2138-44.
15. Rui YF, Lui PPY, Rolf CG, et al. Expression of chondro-osteogenic BMPs in clinical samples of patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2012; 35: 1099-107.
16. de Mos M, Koevoet W, van Schie HT, et al. In vitro model to study chondrogenic differentiation in tendinopathy. Am J Sports Med. 2009; 37: 1214-22.
17. Shi S, Gronthos S. Perivascualr niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res. 2003; 18: 696-704.
18. da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119: 2204-13.
19. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3: 301-13.
20. Lin G, Garcia M, Ning H, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008; 17: 1053-63.
21. Zannettino AC, Paton S, Arthur A, et al. Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. J Cell Physiol. 2008; 214: 413-21.
22. da Silva Meirelles L, Sand TT, Harman RJ, et al. MSC frequency correlates with blood vessel density in equine adipose tissue. Tissue Eng Part A. 2009; 15: 221-9.
23. Caplan A. Why are MSCs therapeutic? New data: new insight. Pathol. 2009; 217: 318-24.
24. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26: 2287-99.
25. Caplan AI. All MSCs are pericytes? Cell Stem Cell. 2008; 3: 229-30.
26. Doherty MJ, Ashton BA, Walsh S, et al. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res. 1998; 13: 828-38.
27. Schor AM, Canfield AE, Sutton AB, et al. Pericyte differentiation. Clin Orthop Relat Res. 1995; 313: 81-91.
28. Brighton CT, Lorich DG, Kupcha R, et al. The pericyte as a possible osteoblast progenitor cell. Clin Orthop Relat Res. 1992; 275: 287-99.
29. Farrington-Rock C, Crofts N, Doherty MJ, et al. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation. 2004; 110: 2226-32.
30. Chen CW, Montelatici E, Crisan M, et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev. 2009; 20: 429-34.
31. Maier CL, Pober JS. Human placental pericytes poorly stimulate and actively regulate allogeneic CD4 T cell responses. Arterioscler Thromb Vasc Biol. 2011; 31: 183-9.
32. Feng J, Mantesso A, De Bari C, et al. Dual origin of mesenchymal stem cells contributing to organ growth and repair. Proc Natl Acad Sci USA. 2011; 108: 6503-8.
33. Lin CS, Xin ZC, Deng CH, et al. Defining adipose tissue-derived stem cells in tissue and in culture. Histol Histopathol. 2010; 25: 807-15.
34. Majesky MW, Dong XR, Hoglund V, et al. The adventitia: a dynamic interface containing resident progenitor cells. Arterioscler Thromb Vasc Biol. 2011; 31: 1530-9.
35. Hoshino A, Chiba H, Nagai K, et al. Human vascular adventitial fibroblasts contain mesenchymal stem/progenitor cells. Biochem Biophys Res Commun. 2008; 368: 305-10.
36. Tintut Y, Alfonso Z, Saini T, et al. Multilineage potential of cells from the artery wall. Circulation. 2003; 108: 2505-10.
37. Pasquinelli G, Tazzari PL, Vaselli C, et al. Thoracic aortas from multiorgan donors are suitable for obtaining resident angiogenic mesenchymal stromal cells. Stem Cells. 2007; 25: 1627-34.
38. Campagnolo P, Cesselli D, Al Haj ZA, et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation. 2010; 121: 1735-45.
39. Tempfer H, Wagner A, Gehwolf R, et al. Perivascular cells of the supraspinatus tendon express both tendon- and stem cell- related markers. Histochem Cell Biol. 2009; 131: 733-41.
40. Mienaltowski MJ, Birk DE. Characterizing progenitor status of cells within the mouse Achilles tendon. In Proceedings of 57th Annual Meeting of the Orthopaedic Research Society, 13th-16th Jan, 2011, Long Beach, California, USA.
41. Tan Q, Rui YF, Lui PP. Characterization of tendon stem/progenitor cells in tendon tissue in vivo. In Proceedings of 58th Annual Meeting of the Orthopaedic Research Society, 4th-7th Feb, 2012, San Francisco, California, USA.
42. Theobald P, Benjamin M, Nokes L, et al. Review of the vascularization of the human Achilles tendon. Injury. 2005; 36: 1267-72.
43. Lee WYW, Lui PPY, Rui YF. Hypoxia mediated efficient expansion of human tendon-derived stem cells (hTDSCs) in vitro. Tissue Eng Part A. 2012; 18: 484-98.
44. Mienaltowski MJ, Adams SM, Birk DE. Regional differences in stem cell/progenitor cell populations from the mouse Achilles tendon. Tissue Eng Part A. 2012; doi 10.1089/ten.TEA.2012.0182.
45. Kurth TB, Dell'Accio F, Crouch V, et al. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum. 2011; 63: 1289-300.
46. Scheffler IE. Mitochondria, 2nd edn. New York: Wiley-Liss; 2008. 168-223.
47. 2 tension and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA. 2005; 102: 4783-8.
48. Forristal CE, Wright KL, Hanley NA, et al. Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction. 2010; 139: 85-97.
49. Fehrer C, Brunauer R, Laschober G, et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell. 2007; 6: 745-57.
50. Yoshida Y, Takahashi K, Okita K, et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009; 5: 237-41.
51. Benjamin M, Ralphs JR. Tendons and ligaments - an overview. Histol Histopathol. 1997; 12: 1135-44.
52. Fu SC, Chan KM, Rolf CG. Increased deposition of sulfated glycosaminoglycans in human patellar tendinopathy. Clin J Sport Med. 2007; 17: 129-34.
53. Zhang J, Li B, Wang JHC. The role of engineered tendon matrix in the stemness of tendon stem cells in vitro and the promotion of tendon-like tissue formation in vivo. Biomaterials. 2011; 32: 6972-81.
54. Yin Z, Chen X, Chen JL, et al. The regulation of tendon stem cell differentiation by the alignment of nanofibers. Biomaterials. 2010; 31: 2163-75.
55. Rui YF, Lui PPY, Ni M, et al. Mechanical loading increased BMP-2 expression which promoted osteogenic differentiation of tendon-derived stem cells. J Orthop Res. 2011; 29: 390-6.
56. Zhang J, Wang JHC. Mechanical response of tendon stem cells: implications of tendon homeostasis and pathogenesis of tendinopathy. J Orthop Res. 2010; 28: 639-43.
57. Zhang J, Pan T, Liu Y, et al. Mouse treadmill running enhances tendons by expanding the pool of tendon stem cells (TSCs) and TSC-related cellular production of collagen. J Orthop Res. 2010; 28: 1178-83.
58. Sussmilch-Leitch SP, Collins NJ, Bialocerkowski AE, et al. Physical therapies for Achilles tendinopathy: systematic review and meta-analysis. J Foot Ankle Res. 2012; 5: 15.
59. Yee Lui PP, Wong YM, Rui YF, et al. Expression of chondro-osteogenic BMPs in ossified failed tendon healing model of tendinopathy. J Orthop Res. 2011; 29: 816-21.
60. Lee YW, Lui PPY, Wong YM, et al. Expression of Wnt pathway mediators in metaplasic tissue in animal model and clinical samples of tendinopathy - Potential effects of Wnts on the erroneous differentiation of tendon-derived stem cells (TDSCs) in the pathogenesis. In Proceedings of 58th Annual Meeting of the Orthopaedic Research Society, 4th-7th Feb, 2012, San Francisco, California, USA.
61. Rui YF, Lui PPY, Wong YM, et al. BMP-2 stimulated non-tenogenic differentiation and promoted proteoglycan deposition of tendon-derived stem cells (TDSCs) in vitro. J Orthop Res. 2012; doi: 10.1002/jor.22290.
62. Hoffmann A, Pelled G, Turgeman G, et al. Neotendon formation induced by manipulation of the Smad8 signaling pathway in mesenchymal stem cells. J Clin Invest. 2006; 116: 940-52.
63. Yoshizawa T, Takizawa F, Iizawa F, et al. Homeobox protein MSX2 acts as a molecular defense mechanism for preventing ossification in ligament fibroblasts. Mol Cell Biol. 2004; 24: 3460-72.
64. McNeilly CM, Banes AJ, Benjamin M, et al. Tendon cells in vivo form a three dimensional network of cell processes linked by gap junctions. J Anat. 1996; 189: 593-600.
65. Popescu LM, Nicolescu MI. Telocytes and stem cells. In: dos Santos Goldenberg RC, de Carvalho ACC, editors. Resident stem cells and regenerative therapy. MA: Academic Press; 2013. pp. 205-31.
66. Popescu LM, Gherghiceanu M, Kostin S, et al. Telocytes and heart renewing. In: Wang P, Kuo CH, Takeda N, Singal PK, editors. Adaptation biology and medicine. New Delhi: Narosa; 2011. pp. 17-39.
67. Gherghiceanu M, Popescu LM. Cardiomyocyte precursors and telocytes in epicardial stem cell niche: electron microscope images. J Cell Mol Med. 2010; 14: 871-7.
68. Manole CG, Cismasiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J Cell Mol Med. 2011; 15: 2284-96.
69. Rui YF, Lui PP, Wong YM, et al. Altered fate of tendon-derived stem cells (TDSCs) isolated from a failed tendon healing animal model of tendinopathy. Stem Cells Dev. 2012; doi: 10.1089/scd.2012.0555 [Epub ahead of print].
70. Wong YM, Lui PPY, Rui YF, et al. Tendon-derived stem cells (TDSCs) isolated from the collagenase-induced failed healing animal model of tendinopathy exhibited higher sensitivity to the BMP/Smad signaling pathway. In Proceedings of 58th Annual Meeting of the Orthopaedic Research Society, 4th-7th Feb, 2012, San Francisco, California, USA.
71. Woo SL, Hildebrand K, Watanabe N, et al. Tissue engineering of ligament and tendon healing. Clin Orthop Relat Res. 1999; 367: S312-23.
72. Kajikawa Y, Morihara T, Watanabe N, et al. GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. J Cell Physiol. 2007; 210: 684-91.
73. Péault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther. 2007; 15: 867-77.
74. Buckley CT, Vinardell T, Thorpe SD, et al. Functional properties of cartilaginous tissues engineered from infrapatellar fat pad-derived mesenchymal stem cells. J Biomech. 2010; 43: 920-6.
75. Caplan AI, Denis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076-84.
76. Park KS, Kim YS, Kim JH, et al. Trophic molecules derived from human mesenchymal stem cells enhance survival, function, and angiogenesis of isolated islets after transplantation. Transplantation. 2010; 89: 509-17.
77. Halfon S, Abramov N, Grinblat B, et al. Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 2011; 20: 53-66.
78. Alt E, Yan Y, Gehmert S, et al. Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell. 2011; 103: 197-208.
79. Dudhia J, Becerra P, Valdes MA, et al. Tracking of mesenchymal stem cells in tendon injuries following in vivo administration. In Proceedings of the International Symposium on Ligaments & Tendons (ISL&T)-XII, 3rd Feb, 2012, San Francisco, California, USA.
80. Hari D, Xin HW, Jaiswal K, et al. Asymmetric cell division via nonrandom chromosomal cosegregation from human cancers. Stem Cell Dev. 2011; 20: 1649-58.
81. Morrison SJ, Prowse KR, Ho P, et al. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity. 1996; 5: 207-16.
82. Breault DT, Min IM, Carlone DL, et al. Generation of mTert-GFP mice as a model to identify and study tissue progenitor cells. Proc Natl Acad Sci USA. 2008; 105: 10420-5.
83. Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009; 91: 652-63.
84. Speer MY, Yang HY, Brabb T, et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009; 104: 733-41.
85. Lui PP, Rui YF, Ni M, et al. Tenogenic differentiation of stem cells for tendon repair - what is the current evidence? J Tissue Eng Regen Med. 2011; 5: e144-63.